MSB 3.21% $1.13 mesoblast limited

Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-160

  1. 403 Posts.
    lightbulb Created with Sketch. 63
    65% wow!! You don't need to be an expert to read between those lines... As a pharmaceutical rookie... can someone please explain the next steps here? What are the next catalysts please....? Thanks in advance.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.